eGoGames and UNAV hold a charity eSports tournament for rare childhood diseases

Playing Bubble Shooter and knowing you're contributing to a good cause. That's the idea behind the University of Navarra through CIMA (Center for Applied Medical Research) and eGoGames, the leading mobile eSports platform in Europe, as they organize this tournament, with all proceeds going towards research into rare childhood diseases. United for this common good, UNAV and eGoGames have agreed that 100% of the funds raised will go towards financing a €35,000 research grant at CIMA. The "TanTanTan Valientes" tournament, organized in honor of Rare Disease Day on February 28th, will reward the competitors' solidarity with 10 symbolic trophies and will take place between February 26th and March 5th.

The competition, in which players use their skills to pop bubbles of the same color that are connected in any direction, will also tally the specific disease the research will target. For instance, by eliminating blue bubbles, players contribute to brain tumor research; green bubbles help fight soft tissue tumors; and red bubbles, bone tumors. Additionally, the total number of purple bubbles popped will support research into rare brain diseases, orange bubbles will target rare kidney diseases, and pink bubbles will focus on liver diseases. Each game played costs €2, with no geographical restrictions. The trophies, which will reward the top 10 donors with the highest Bubble Shooter scores, include a UNAV sweatshirt, wireless headphones, a power bank, a tie and socks from La Fábrica, a pendant from Spanish&Sisters, a T-shirt, or a UNAV cotton bag.

February 28th, Rare Disease Day
In the European Union alone, there are approximately 7,000 different rare diseases, each affecting a small portion of the population. Most have no cure and are chronic. The life expectancy of those affected depends on the individual and the type of illness, and curative therapies must necessarily come from research. In Spain, more than 3 million people are affected by rare diseases, while globally, they affect 6 to 8% of the total population: between 27 and 36 million people. 80% of these rare diseases are genetic and congenital in origin: they must be understood in order to be defeated. Therefore, the primary focus of research is Gene Therapy.

‍